XML 67 R53.htm IDEA: XBRL DOCUMENT
v3.21.2

SUBSEQUENT EVENTS (Details) - USD ($) $ in Thousands |  |  |  |  | 9 Months Ended
--- | --- | --- | --- | --- | ---
Aug. 02, 2021 | Jul. 16, 2021 | Jul. 15, 2021 | Jul. 09, 2021 | Jun. 30, 2021 | Jun. 30, 2020
SUBSEQUENT EVENTS |  |  |  |  |  |
Consideration in cash |  |  |  |  | $ 40,698 | $ 4,000
Subsequent events | BioReliance and BASi Gaithersburg |  |  |  |  |  |
SUBSEQUENT EVENTS |  |  |  |  |  |
Consideration for acquisition in sales royalties in connection with future net sales related (as a percent) |  |  |  | 10.00% |  |
Subsequent events | Laboratory Instrumentation |  |  |  |  |  |
SUBSEQUENT EVENTS |  |  |  |  |  |
Consideration in cash |  |  | $ 1,300 |  |  |
Subsequent events | Gateway Pharmacology Laboratories LLC |  |  |  |  |  |
SUBSEQUENT EVENTS |  |  |  |  |  |
Consideration in cash | $ 1,400 |  |  |  |  |
Shares issued | 45,323 |  |  |  |  |
Common shares value | $ 1,250 |  |  |  |  |
Subsequent events | PPP Loan |  |  |  |  |  |
SUBSEQUENT EVENTS |  |  |  |  |  |
Forgiveness of debt |  | $ 4,851 |  |  |  |

X
- Definition Consideration for the acquisition, in sales royalties in connection with future net sales related. + References No definition available. + Details
Name: | notv_SalesRoyaltiesInConnectionWithFutureNetSales
Namespace Prefix: | notv_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gross amount of debt extinguished. + References No definition available. + Details
Name: | us-gaap_ExtinguishmentOfDebtAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(1) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References No definition available. + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=notv_BioRelianceCorporationAndBSIGaithersburgLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=notv_LaboratoryInstrumentationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=notv_GatewayPharmacologyLaboratoriesLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=notv_PaycheckProtectionProgramLoanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |